Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada.

Autor: Fischer B; Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, 1023, New Zealand; Department of Psychiatry, University of Toronto, 250 College Street 8th floor, Toronto, Ontario, M5T 1R8, Canada; Centre for Applied Research in Mental Health and Addiction (CARMHA), Faculty of Health Sciences, Simon Fraser University, Suite 2400 515 W. Hastings Street, Vancouver, British Columbia, V6B 5K3, Canada; Department of Psychiatry, Federal University of São Paulo (UNIFESP), R. Dr. Ovídio Pires de Campos, 785 05403-90, São Paulo, Brazil. Electronic address: bfischer@sfu.ca., Jones W; Centre for Applied Research in Mental Health and Addiction (CARMHA), Faculty of Health Sciences, Simon Fraser University, Suite 2400 515 W. Hastings Street, Vancouver, British Columbia, V6B 5K3, Canada., Hall W; Centre for Youth Substance Abuse Research (CYSAR), K Floor Mental Health Centre, The University of Queensland, Royal Brisbane and Women's Hospital Site, Herston, Queensland, 4029, Australia; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, United Kingdom., Kurdyak P; Institute for Mental Health Policy Research (IMHPR), Centre for Addiction and Mental Health (CAMH), 33 Russell Street, Toronto, Ontario, M5S 2S1, Canada; Department of Psychiatry, University of Toronto, 250 College Street 8th floor, Toronto, Ontario, M5T 1R8, Canada; Institute for Clinical Evaluative Sciences (ICES), 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada.
Jazyk: angličtina
Zdroj: The International journal on drug policy [Int J Drug Policy] 2019 Nov; Vol. 73, pp. 96-99. Date of Electronic Publication: 2019 Aug 10.
DOI: 10.1016/j.drugpo.2019.06.020
Databáze: MEDLINE